Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Hastings › NPI 1023001146
Hospital

Pennock Hospital

Pennock Hospital was paid $1.31M by Medicaid between Jan 2018 and Jun 2019, across 121 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.

33Billing provider infoPENNOCK HOSPITAL
HASTINGS, MI 49058
33aNPI1023001146assigned 08/24/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.31M
24GClaims53,459
24DCodes billed121
24AFirst – last monthJan 2018 – Jun 2019
Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#74 of 86
Median peer was paid$21.55M
This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201847,779$1.16M
20195,680$140K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 1,528 1,417 $267K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 18% 4,230 3,834 $231K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 725 677 $191K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 1,570 1,491 $171K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7.5% 1,086 995 $98K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 352 340 $40K
71046 Radiologic examination, chest; 2 views 2.2% 994 947 $28K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 1,069 312 $26K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.0% 416 400 $26K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 289 259 $23K
96375 Therapeutic injection; each additional sequential IV push 1.5% 887 762 $19K
96361 Intravenous infusion, hydration; each additional hour 1.3% 584 490 $17K
109 more codes
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.3% 665 $17K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.2% 621 $15K
70450 Computed tomography, head or brain; without contrast material <1% 230 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 104 $10K
80061 Lipid panel <1% 731 $9K
77067 Screening mammography, bilateral, including computer-aided detection <1% 177 $8K
80053 Comprehensive metabolic panel <1% 2,932 $7K
86900 <1% 185 $7K
84443 Thyroid stimulating hormone (TSH) <1% 1,005 $7K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 55 $6K
36415 Collection of venous blood by venipuncture <1% 4,618 $5K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 422 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 2,650 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 67 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 72 $4K
76830 Ultrasound, transvaginal <1% 57 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 58 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 175 $3K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 173 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 883 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 352 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 444 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 369 $2K
85027 <1% 801 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 703 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 348 $1K
87081 <1% 1,052 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 182 $1K
86780 <1% 146 $1K
80048 Basic metabolic panel (calcium, ionized) <1% 358 $1K
87653 <1% 53 $1K
73630 <1% 169 $1K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening <1% 113 $983.06
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 618 $913.64
87077 <1% 331 $694.46
84439 <1% 150 $669.30
72100 <1% 29 $643.77
82947 <1% 219 $615.12
73130 <1% 127 $578.67
81001 <1% 1,702 $561.98
87186 <1% 255 $560.09
73562 <1% 81 $558.23
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 26 $532.50
97162 <1% 13 $503.40
73610 <1% 104 $473.04
82728 <1% 57 $462.44
85610 <1% 419 $462.21
82607 <1% 48 $403.34
86140 <1% 585 $400.79
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 12 $381.23
86703 <1% 61 $369.79
87205 <1% 300 $336.61
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 26 $312.64
83880 <1% 74 $294.60
97161 <1% 15 $290.29
80305 <1% 142 $263.53
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 446 $252.57
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 724 $243.71
84702 <1% 42 $208.33
85007 <1% 289 $203.10
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 29 $201.90
87340 <1% 62 $185.40
83735 <1% 109 $178.50
86762 <1% 37 $163.44
82570 <1% 58 $158.81
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 14 $153.15
83690 <1% 586 $147.21
85652 <1% 158 $141.13
87070 <1% 65 $130.35
82950 <1% 43 $125.61
87147 <1% 128 $118.86
85730 <1% 217 $93.09
73564 <1% 13 $81.56
81025 <1% 974 $79.06
82043 <1% 13 $47.55
86850 <1% 160 $46.37
84484 <1% 430 $19.05
81003 <1% 70 $18.69
87807 <1% 66 $15.06
81002 <1% 396 $14.15
87040 <1% 30 $12.97
83605 <1% 400 $6.71
85379 <1% 12 $6.39
J1885 Injection, ketorolac tromethamine, per 15 mg 0% 845 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 395 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 326 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 600 $0.00
96376 0% 182 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 124 $0.00
J2704 Injection, propofol, 10 mg 0% 389 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 350 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 97 $0.00
A9270 Non-covered item or service 0% 154 $0.00
86901 0% 88 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 30 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 107 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 148 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 211 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 410 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 308 $0.00
90715 0% 44 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 0% 987 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 465 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 1,336 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 32 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 124 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 16 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 0% 14 $0.00
87420 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEWIS-BLAKE, SHERYL (PRESIDENT)